Cyclosporine — products, DINs, and Canadian availability
This page lists Health Canada–registered pharmaceutical products whose active ingredient list includes Cyclosporine. We track 29 distinct Drug Identification Numbers (DINs) for this molecule, of which 20 are currently in marketed status. Across those registrations there are 10 manufacturers or marketing authorization holders, 5 dosage forms, and 8 distinct strength presentations.
Procurement teams normally arrive here for one of three reasons: a specific brand is unavailable and an equivalent registration is needed; a clinical protocol requires a comparator containing Cyclosporine in a defined strength; or a pharmacy needs to know which manufacturers still hold an active Canadian registration before committing to a substitution. The table below answers the first question directly. For the second and third, Nexara Health can confirm live availability, remaining shelf life, and landed cost from Canadian stock or from any of more than 40 regulated international source markets.
Registration status is not the same as availability. A product can hold marketed status in the Drug Product Database and still be on allocation, discontinued by the holder, or unavailable in the pack size a hospital needs. Where a Cyclosporine product is in shortage, our Canadian drug shortage tracker carries the reported status, the reason where the manufacturer has published one, and the marketed alternatives sharing the same active ingredient.
Dosage forms and strengths recorded for Cyclosporine
Dosage forms: Solution, Capsule, Ointment, Emulsion, Liquid. Strengths: 100 MG, 50 MG, 25 MG, 10 MG, 0.09 %, 2 MG, 0.05 %, 0.1 %.
Manufacturers and marketing authorization holders
APOTEX INC, ELANCO CANADA LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, EDENBRIDGE PHARMACEUTICALS, LLC, SANDOZ CANADA INCORPORATED, NOVARTIS PHARMACEUTICALS CANADA INC, INTERVET CANADA CORP, ABBVIE CORPORATION, SANDOZ CANADA INC, TEVA CANADA LIMITED.
Registered products containing Cyclosporine
| DIN | Product | Manufacturer | Strength | Dosage form | Status |
|---|---|---|---|---|---|
| 02244324 | APO-CYCLOSPORINE ORAL SOLUTION | APOTEX INC | 100 MG | Solution | Cancelled Post Market |
| 02282062 | ATOPICA | ELANCO CANADA LIMITED | 50 MG | Capsule | Marketed |
| 02282054 | ATOPICA | ELANCO CANADA LIMITED | 25 MG | Capsule | Marketed |
| 02282046 | ATOPICA | ELANCO CANADA LIMITED | 10 MG | Capsule | Marketed |
| 02282070 | ATOPICA | ELANCO CANADA LIMITED | 100 MG | Capsule | Marketed |
| 02382490 | ATOPICA FOR CATS | ELANCO CANADA LIMITED | 100 MG | Solution | Marketed |
| 02512629 | CEQUA | SUN PHARMACEUTICAL INDUSTRIES LIMITED | 0.09 % | Solution | Marketed |
| 02495821 | CYCLOSPORINE | EDENBRIDGE PHARMACEUTICALS, LLC | 50 MG | Capsule | Dormant |
| 02495813 | CYCLOSPORINE | EDENBRIDGE PHARMACEUTICALS, LLC | 100 MG | Capsule | Dormant |
| 02495805 | CYCLOSPORINE | EDENBRIDGE PHARMACEUTICALS, LLC | 25 MG | Capsule | Dormant |
| 02334763 | CYCLOSPORINE | SANDOZ CANADA INCORPORATED | 25 MG | Capsule | Cancelled Pre Market |
| 02150670 | NEORAL | NOVARTIS PHARMACEUTICALS CANADA INC | 100 MG | Capsule | Marketed |
| 02150689 | NEORAL | NOVARTIS PHARMACEUTICALS CANADA INC | 25 MG | Capsule | Marketed |
| 02150662 | NEORAL | NOVARTIS PHARMACEUTICALS CANADA INC | 50 MG | Capsule | Marketed |
| 02150697 | NEORAL | NOVARTIS PHARMACEUTICALS CANADA INC | 100 MG | Solution | Marketed |
| 02237671 | NEORAL | NOVARTIS PHARMACEUTICALS CANADA INC | 10 MG | Capsule | Marketed |
| 02142155 | OPTIMMUNE | INTERVET CANADA CORP | 2 MG | Ointment | Marketed |
| 02355655 | RESTASIS | ABBVIE CORPORATION | 0.05 % | Emulsion | Marketed |
| 02476835 | RESTASIS MULTIDOSE | ABBVIE CORPORATION | 0.05 % | Emulsion | Marketed |
| 01907182 | SANDIMMUNE CAP 50MG | SANDOZ CANADA INC | 50 MG | Capsule | Cancelled Post Market |
| 00593257 | SANDIMMUNE I.V. | NOVARTIS PHARMACEUTICALS CANADA INC | 50 MG | Solution | Marketed |
| 00593249 | SANDIMMUNE ORAL SOL 100MG/ML | SANDOZ CANADA INC | 100 MG | Liquid | Cancelled Post Market |
| 00755605 | SANDIMMUNE SOFT GELATIN CAP 100MG | SANDOZ CANADA INC | 100 MG | Capsule | Cancelled Post Market |
| 00755591 | SANDIMMUNE SOFT GELATINE CAP 25MG | SANDOZ CANADA INC | 25 MG | Capsule | Cancelled Post Market |
| 02247073 | SANDOZ CYCLOSPORINE | SANDOZ CANADA INCORPORATED | 25 MG | Capsule | Marketed |
| 02242821 | SANDOZ CYCLOSPORINE | SANDOZ CANADA INCORPORATED | 100 MG | Capsule | Marketed |
| 02247074 | SANDOZ CYCLOSPORINE | SANDOZ CANADA INCORPORATED | 50 MG | Capsule | Marketed |
| 02462486 | TEVA-CYCLOSPORINE | TEVA CANADA LIMITED | 0.05 % | Emulsion | Marketed |
| 02484137 | VERKAZIA | APOTEX INC | 0.1 % | Emulsion | Marketed |
Sourcing Cyclosporine through a licensed wholesaler
Nexara Health imports and distributes under Health Canada Drug Establishment Licence #3-002896. For Cyclosporine we can quote Canadian-marketed presentations, equivalent registrations from the EU, UK, US, Switzerland, Australia, and Japan where the Canadian presentation is unavailable, and comparator-grade supply with Certificate of Analysis, batch and expiry records, and full chain of custody for clinical trial use. Cold-chain presentations ship under GDP conditions with continuous temperature monitoring.
Request a quote
Nexara Health is a Health Canada–licensed pharmaceutical wholesaler (DEL #3-002896) based in Winnipeg, Manitoba, supplying hospitals, pharmacies, clinics, CROs, and trial sponsors across Canada. Send us the product, strength, presentation, and quantity for Cyclosporine and we will come back with availability, source market, lead time, and landed cost — usually within 24 hours.
Request a sourcing quote or call +1 (431) 588-9055.